Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Clinical trial NCT05304715 · COMPLETED

Trial details

NCT number: NCT05304715
Sponsor: Hellenic Institute for the Study of Sepsis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridioides Difficile Infection Stool Microbiome Organ Dysfunction Syndrome Clostridioides Difficile Infection Recurrence Mortality

Start date: 2022-04-13
Primary completion: 2023-06-04
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.